Utah Medical Products UTMD Increase (Decrease) in Accounts Receivable and Other Operating Assets

Increase (Decrease) in Accounts Receivable and Other Operating Assets at other companies

TFS FinancialTFSL

-$142K—

TRG

Targa ResourcesTRGP

$198M+191%

Realty IncomeO

$114.38M+19.9%

NXP SemiconductorsNXPI

$115M+297%

Cherry Hill Mortgage InvestmentCHMI

-$2.55M-3.4%

Ferguson EnterprisesFERG

$275M+127%

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's increase (decrease) in accounts receivable and other operating assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's increase (decrease) in accounts receivable and other operating assets?: Utah Medical Products (UTMD) reported increase (decrease) in accounts receivable and other operating assets of $130K in Q1 2026.
How has Utah Medical Products's increase (decrease) in accounts receivable and other operating assets changed year-over-year?: Utah Medical Products's increase (decrease) in accounts receivable and other operating assets increased by 1183.3% year-over-year, from -$12K to $130K.